View Author
scopus: 35433715600

Wraith, J.E.

(James Wraith)


patient disease mps ii study syndrome treatment therapy mutation enzyme hunter hunter syndrome change mucopolysaccharidosis type ii baseline enzyme replacement therapy mucopolysaccharidosi idursulfase month children infusion lysosomal diagnosis laronidase airway group hurler syndrome pompe trial rhgaa activity hurler level shire transplantation mps i genzyme corporation replacement hospital symptom assessment genet lysosomal storage diseases report manifestation antibody wraith pediatr airway obstruction university storage effect orphanet journal genzyme disorder 18 months support glycogen muscle swets blackwell 76157563 infantile-onset pompe disease motor mucopolysaccharidose deficiency pediatrics glycosaminoglycan family department improvement article bone marrow transplantation management development function death residue involvement pompe disease hgsnat control group lysosomal lumen changes




5 Most Recent Publications

Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease (Article)
Scarpa, M. Almássy, Z. Kamin, W. Kampmann, C. Lampe, C. Lavery, C.A. Leão Teles, E. Link, B. Lund, A.M. Malm, G. Pitz, S. Rothera, M. Beck, M. Stewart, C. Tylki-Szymaska, A. Ploeg, A.T. van der Walker, R. Zeman, J. Wraith, J.E. Bodamer, O.A. Bruce, I.A. Meirleir, L. de Guffon, N. Guillen-Navarro, E. Hensman, P. Jones, S.
2011-11-08
Sanfilippo syndrome type C: Mutation spectrum in the heparan sulfate acetyl-CoA: α-glucosaminide N-acetyltransferase (HGSNAT) gene (Article)
Feldhammer, M. Durand, S. Kmoch, S. Pshezhetsky, A.V. Mrázová, L. Boucher, R.M. Laframboise, R. Steinfeld, R. Wraith, J.E. Michelakakis, H. Diggelen, O.P. van Hřebíček, M.
2009-06-01
Mucopolysaccharidosis type II (Hunter syndrome): A clinical review and recommendations for treatment in the era of enzyme replacement therapy (Article)
Wraith, J.E. Scarpa, M. Beck, M. Bodamer, O.A. Meirleir, L. de Guffon, N. Meldgaard Lund, A. Malm, G. Ploeg, A.T. van der Zeman, J.
2008-03-01
Enzyme replacement therapy in patients who have mucopolysaccharidosis i and are younger than 5 years: Results of a multinational study of recombinant human α-L-iduronidase (laronidase) (Article)
Wraith, J.E. Beck, M. Lane, R. Ploeg, A.T. van der Shapiro, E. Xue, Y. Kakkis, E.D. Guffon, N.
2007-07-01
Recombinant human acid α-glucosidase: Major clinical benefits in infantile-onset Pompe disease (Article)
Kishnani, P.S. Corzo, D. Li, J.S. Dumontier, J. Halberthal, M. Chien, Y.H. Hopkin, R. Vijayaraghavan, S. Gruskin, D. Bartholomew, D. Ploeg, A.T. van der Clancy, J.P. Nicolino, M. Parini, R. Morin, G. Beck, M. La Gastine, G.S. de Jokic, M. Thurberg, B. Richards, S. Bali, D. Davison, M. Worden, M.A. Byrne, B. Chen, Y.T. Wraith, J.E. Mandel, H. Hwu, W.L. Leslie, N. Levine, J. Spencer, C. McDonald, M.
2007-01-01